At Voima Ventures, we back founders with bold ambitions and the science that dares to shift the world. Today, we’re proud to announce our lead investment in Hormona (hormona.io, London/Stockholm), the health-tech company using AI and at-home testing to help women track, understand, and optimize their hormones.
Hormona is more than a product — it’s a movement and a direct answer to the decades-long silence and stigma surrounding women’s hormonal health. Founded by women, for women, Hormona is unlocking access to personalized hormone tracking with lab-level accuracy — without the barriers, wait times, or guesswork that have long defined women’s healthcare.
“We invest in the impossible — and Hormona is doing what once seemed impossible: giving millions of women control over their own biology through tech, data, and relentless empathy,” says Inka Mero, Founder and Managing Partner at Voima Ventures. “They are not just building a company — they are redefining what healthcare means for half the population.”
Hormona’s oversubscribed $6.7M Seed round was co-led by Supernode VC (London), with participation from DLF Ventures (Brussels), Nascent Invest (Sweden), and Techstars (US). The funding will power the global launch of Hormona’s first-of-its-kind quantitative hormone tests, expand B2B partnerships, and accelerate the platform’s technology, reach, and impact.
Hormona: Technology with Purpose
Hormona’s mission is deeply personal. CEO and co-founder Karolina Löfqvist spent years suffering from hormone-related symptoms without a clear diagnosis — a reality shared by 80% of women worldwide. That experience fueled the company’s creation: a science-backed solution to help women take control of their hormonal health.
“For too long, women have had to suffer through hormonal issues, relying on trial and error and waiting until symptoms become unbearable. That’s no way to live,” Löfqvist says. “We built Hormona to change that — to make real-time hormone tracking accessible, without the need for repeated blood draws. This investment brings us one step closer to that future.”
Founders from left to right. Jasmine Tagesson (COO), Karolina Löfqvist (CEO)
Hormona combines AI-powered insights with at-home hormone testing to help women detect imbalances, track fluctuations, and better manage conditions like PCOS, irregular cycles, and perimenopause. The company’s proprietary testing tech is over 90% accurate compared to venous blood sampling, while offering continuous, affordable tracking — eliminating the need for clinical labs.
Why We Invested in Hormona
- A $44B market that is still underserved
Hormonal health is one of the most overlooked areas in medicine. Hormona combines scientific precision, emotional intelligence, and retention-driven UX to address this global gap. - Deep tech meets deep need
Hormona’s solution delivers actionable, personalized data in a category long ruled by guesswork — setting a new standard for scalable, meaningful digital health. - Purpose-led founder-market fit
Built from lived experience and powered by clinical collaboration, Hormona is led by a team uniquely equipped to solve this challenge with authenticity and ambition. - A fast-growing, global platform
With downloads in 190+ countries, 30% monthly growth, and a social reach of 100M+ views, Hormona is proof that women everywhere are ready for a new health paradigm.
Hormona is already a leader in femtech — and with the support of science-driven investors like us, they’re scaling into a category of their own.
The Future Is Personalized, Predictive, and Female-Led
This investment aligns with our core thesis: to back scientifically validated, user-centric solutions solving systemic health challenges, also for women. We believe that the future of healthcare lies at the intersection of data, empathy, and inclusivity.
And we’re just getting started. Please keep following us for more content on this topic.
Read more about Hormona in the latest Sifted article.
About Hormona
Featured by Vogue, Daily Express and Forbes, Hormona (hormona.io) is a London-based women’s health company using AI and first-of-their-kind at-home testing to empower women to understand and manage their hormone health. Co-founded in 2020 by Karolina Löfqvist (CEO) and Jasmine Tagesson (COO), Hormona provides personalised hormone tracking and expert-backed guidance to help women address hormonal imbalances and related conditions. The company collaborates with a team of endocrinologists, gynaecologists, and nutritionists to deliver science-backed insights. With a team of 12, Hormona has raised $8.6M/£6.5M to date from investors including Voima Ventures and SuperNode Global VC.
